Docking Characterization and in Vitro Inhibitory Activity of Flavan-3-Ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2
Total Page:16
File Type:pdf, Size:1020Kb
ORIGINAL RESEARCH published: 30 November 2020 doi: 10.3389/fpls.2020.601316 Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2 Yue Zhu and De-Yu Xie* Department of Plant and Microbial Biology, North Carolina State University, Raleigh, NC, United States We report to use the main protease (Mpro) of SARS-Cov-2 to screen plant flavan-3-ols and proanthocyanidins. Twelve compounds, (–)-afzelechin (AF), (–)-epiafzelechin (EAF), (+)-catechin (CA), (–)-epicatechin (EC), (+)-gallocatechin (GC), (–)-epigallocatechin Edited by: (EGC), (+)-catechin-3-O-gallate (CAG), (–)-epicatechin-3-O-gallate (ECG), Guodong Wang, Chinese Academy of Sciences, China (–)-gallocatechin-3-O-gallate (GCG), (–)-epigallocatechin-3-O-gallate (EGCG), Reviewed by: procyanidin A2 (PA2), and procyanidin B2 (PB2), were selected for docking simulation. pro Hiroshi Noguchi, The resulting data predicted that all 12 metabolites could bind to M . The affinity Nihon Pharmaceutical scores of PA2 and PB2 were predicted to be −9.2, followed by ECG, GCG, EGCG, University, Japan Ericsson Coy-Barrera, and CAG, −8.3 to −8.7, and then six flavan-3-ol aglycones, −7.0 to −7.7. Docking Universidad Militar Nueva characterization predicted that these compounds bound to three or four subsites (S1, Granada, Colombia S1′, S2, and S4) in the binding pocket of Mpro via different spatial ways and various *Correspondence: De-Yu Xie formation of one to four hydrogen bonds. In vitro analysis with 10 available compounds pro [email protected] showed that CAG, ECG, GCG, EGCG, and PB2 inhibited the M activity with an IC50 value, 2.98 ± 0.21, 5.21 ± 0.5, 6.38 ± 0.5, 7.51 ± 0.21, and 75.3 ± 1.29 µM, Specialty section: respectively, while CA, EC, EGC, GC, and PA2 did not have inhibitory activities. To This article was submitted to Plant Metabolism and Chemodiversity, further substantiate the inhibitory activities, extracts prepared from green tea (GT), two a section of the journal muscadine grapes (MG), cacao, and dark chocolate (DC), which are rich in CAG, ECG, Frontiers in Plant Science GAG, EGCG, or/and PB2, were used for inhibitory assay. The resulting data showed Received: 31 August 2020 pro Accepted: 06 November 2020 that GT, two MG, cacao, and DC extracts inhibited the M activity with an IC50 value, Published: 30 November 2020 2.84 ± 0.25, 29.54 ± 0.41, 29.93 ± 0.83, 153.3 ± 47.3, and 256.39 ± 66.3 µg/ml, Citation: respectively. These findings indicate that on the one hand, the structural features of Zhu Y and Xie D-Y (2020) Docking flavan-3-ols are closely associated with the affinity scores; on the other hand, the Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric galloylation and oligomeric types of flavan-3-ols are critical in creating the inhibitory Proanthocyanidins Against the Main activity against the Mpro activity. Protease Activity of SARS-Cov-2. Front. Plant Sci. 11:601316. Keywords: flavan-3-ols, flavan-3-ol gallates, procyanidins, COVID-19, green tea, muscadine grape, cacao, dark doi: 10.3389/fpls.2020.601316 chocolate Frontiers in Plant Science | www.frontiersin.org 1 November 2020 | Volume 11 | Article 601316 Zhu and Xie Flavan-3-ols and Proanthocyanidins Against SARS-Cov-2 INTRODUCTION patients (Dai W. et al., 2020; Zhang et al., 2020). Currently, the humans are placing a hope on vaccines. However, no effective SARS-CoV-2 is a novel severe acute respiratory syndrome-related vaccines are ready for prevention. The potential risks of vaccines coronavirus strain and highly contagious to humans (Figure 1). remain largely unknown. Making matters worse, more studies Its infection on humans was reported in the early December have shown that the originality and the transmission of this of 2019 in Wuhan, China (Wang C. et al., 2020; Wu et al., contagious virus are more complicated than the humans know. 2020). On January 30, 2020, The World Health Organization Studies have shown that in addition to aerosol transmission, (WHO) declared the outbreak of the coronavirus disease 2019 this virus can be transmitted through gastrointestinal infection (COVID-19) emergency (World Health Organization, 2020a). (Lamers et al., 2020; Xiao et al., 2020) and can stably stay for 3h On March 11, 2020, WHO announced the COVID-19 pandemic in air and 72h on plastic and steal surfaces (van Doremalen et al., (World Health Organization, 2020b). As of October 22, 2020, 2020). In addition to causing lung diseases, this virus has been it has infected ∼41,561,983 people and caused ∼1,135,289 found to cause other health complications, such as abdominal deaths worldwide (data source from Johns Hopkins Coronavirus pain (Lamers et al., 2020) and neurologic abnormality (Helms Resource Center). These numbers are continuously increasing et al., 2020). To the whole world surprise, one newest study every day. Extremely sadly, the humans do not know when this revealed that SARS-Cov-2 existed in wastewater that had been pandemic will end. Although hydroxychloroquine, chloroquine, stored in Barcelona, Spain since March 2019 (Chavarria-Miró and remdesivir were recommended for treating COVID-19 et al., 2020), the time of which was 9 months earlier than the (Colson et al., 2020; Sehailia and Chemat, 2020; Wang M. first report from Wuhan. This finding implies that SARS-Cov- et al., 2020), their therapeutic effects still remain for studies. For 2 might have been transmitted in humans before the outbreak. In example, a new study showed that chloroquine could not treat summary, no medicines can treat COVID-19 and no vaccines can COVID-19 (Hoffmann et al., 2020). Although 300 trials with prevent this contagious disease. Therefore, effective treatments different anti-virus medicines are being performed (Sanders et al., and preventions are urgently needed. 2020), such as lopinavir and ritonavir (Cao et al., 2020), the fact Flavan-3-ols and proanthocyanidins (PAs) are two groups is that no medicines show therapeutic effectiveness. Although in of plant flavonoids (Figure 2; Xie and Dixon, 2005). They June 2020, dexamethasone, a steroid, was publically reported to commonly exist in fruits, food products, and beverages, such decrease the death risk of COVID-19 patients (Khan and Htar, as grape (Iacopini et al., 2008; Zhu et al., 2014; Yuzuak et al., 2020; Selvaraj et al., 2020), more trials need to be performed to 2018; Rousserie et al., 2019), strawberry (Lopez-Serrano and demonstrate its effectiveness. Furthermore, different proteins or Barcelo, 1997; Fossen et al., 2004; Fischer et al., 2014), persimmon genes of SARS-Cov-2, such as the main protease (Figure 1), have (Akagi et al., 2009), cranberry (Foo et al., 2000a,b), blueberry been targeted to screen medicines, however, no small molecules (Gu et al., 2002), cacao nuts (Murphy et al., 2003; Miller et al., have been conclusively shown to be able to treat COVID-19 2009), chocolate (Schewe et al., 2002; Serafini et al., 2003), FIGURE 1 | A simplified diagram showing the essential function of the main protease involved in SARS-Cov-2 replication in infected host cells. Frontiers in Plant Science | www.frontiersin.org 2 November 2020 | Volume 11 | Article 601316 Zhu and Xie Flavan-3-ols and Proanthocyanidins Against SARS-Cov-2 FIGURE 2 | Structures of (+)-afzelechin, (–)-epiafzelechin, (+)-catechin, (–)-epicatechin, (+)-gallocatechin, (–)-epigallocatechin, (–)-catechin-3-O-gallate, (–)-epicatechin-3-O-gallate, (–)-gallocatechin-3-O-gallate, and (–)-epigallocatechin-3-O-gallate, procyanidin B1 and B2, and procyanidin A1 and A2. green tea (Liu et al., 2012; Zhao et al., 2017; Wang P. et al., two types of structures, the dominant B-type characterized with 2020), and wines (Monagas et al., 2003). Common flavan-3- an interflavan bond only and the uncommon A-type featured ol aglycones in these plant products include (–)-epicatechin with an interflavan bond and an ether linkage (Xie and Dixon, (EC), (+)-catechin (CA), (–)-epigallocatechin (EGC), (+)- 2005). Common dimeric B-types in fruits and beverages include gallocatechin (GC), (–)-epiafzelechin (EAF), and (+)-afzelechin procyanidin B1, B2, B3, and B4. Two examples of dimeric A- (AF) (Figure 2; Xie and Dixon, 2005). Common flavan-3- type PAs are procyanidin A1 and A2 (Xie and Dixon, 2005). ol gallates include (–)-epicatechin-3-O-gallate (ECG), (+)- Flavan-3-ols and PAs are potent antioxidants with multiple catechin-3-O-gallate (CAG), (–)-gallatechin-3-O-gallate (GCG), benefits to human health (Xie and Dixon, 2005). Multiple (–)-epigallocatechin-3-O-galloate (EGCG), which are highly compounds from these two groups, such as CA, EPC, EGC, abundant in green tea (Dai X. et al., 2020; Wang P. et al., EGCG, procyanidin B2, and procyanidin A2 (Figure 2), have 2020). PAs are oligomeric or polymeric flavan-3-ols. In PAs, been shown to have antiviral function (de Bruyne et al., 1999; the lowest and upper units are termed as the starter and Iwasawa et al., 2009), antibacterial activity (Molan et al., 2001; extension units, which are linked by interflavan bonds formed Howell et al., 2005), anticancer (Ohata et al., 2005; Suganuma between the C8 or C6 of a lower unit and the C4 of an et al., 2011), anti-cardiovascular diseases (Loke et al., 2008; upper unit (Figure 2). In addition, a second linkage is a C2- Panneerselvam et al., 2010; MacRae et al., 2019), and anti-aging O-C7 ether bond between the starter unit and the extension diseases (Levites et al., 2003; Li et al., 2004; Weinreb et al., 2004). unit. Based on the linkage numbers, PAs are classified into In particular, the anti-viral activity suggests that flavan-3-ols and Frontiers in Plant Science | www.frontiersin.org 3 November 2020 | Volume 11 | Article 601316 Zhu and Xie Flavan-3-ols and Proanthocyanidins Against SARS-Cov-2 PAs are appropriate targets for screening potential anti-SARS- hydrogens were added and receptor charge was optimized, Cov-2 medicines.